Oleanolic acid-based nanoparticles for the treatment of ulcerative colitis
OA NPs mitigate UC pathology through targeted delivery, enhanced stability, and modulation of inflammatory pathways, providing a promising approach for UC treatment. Further studies are needed to evaluate their long-term safety and clinical applicability.
Authors
- Xinchuang Wang
- Di Wu (ORCID: https://orcid.org/0000-0003-3129-1640)
- Jiangning Hu (ORCID: https://orcid.org/0000-0002-2076-4505)
- Beiwei Zhu (ORCID: https://orcid.org/0000-0003-4674-2993)
- Tao Chen (ORCID: https://orcid.org/0000-0003-2536-4145)
- Dan Zhang (ORCID: https://orcid.org/0000-0002-2247-5141)
- Fengxian Luo
- Yu Xu (ORCID: https://orcid.org/0009-0006-4723-7365)
- Lihang Chen (ORCID: https://orcid.org/0000-0002-8549-4139)
Institutions
- Dalian Polytechnic University (CN)
Publication Details
- Journal
- Nanomedicine
- Published
- 2025-02-23
- DOI
- https://doi.org/10.1080/17435889.2025.2467019
- Citations
- 6
- Primary Topic
- Pharmacological Effects of Natural Compounds
- Type
- article
- Field-Weighted Citation Impact
- 9.34
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China